HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Therapeutic trial with ivermectin in loiasis with medium and high microfilaremia].

Abstract
Treatment with ivermectin at the dosage of 200 microgram/kg in 28 Congolese loiasis patients led to an important decrease of the microfilaremia on day 7, with a reduction of about 90% of the initial parasite load. However, no negativation was observed and, moreover, the parasitemia did not change from day 7 to day 14. Tolerance was quite good, but weak to moderate reactions, linked to the lysis of the microfilariae, were observed in one third of the patients with a microfilaremia greater or equal to 2,500/mm3.
AuthorsB Carme, B Ebikili, A Mbitsi, N Copin
JournalAnnales de la Societe belge de medecine tropicale (Ann Soc Belg Med Trop) Vol. 71 Issue 1 Pg. 47-50 (Mar 1991) ISSN: 0772-4128 [Print] Belgium
Vernacular TitleEssai thérapeutique de l'ivermectine au cours de la loase à moyenne et forte microfilarémie.
PMID2043000 (Publication Type: Journal Article)
Chemical References
  • Ivermectin
Topics
  • Animals
  • Dose-Response Relationship, Drug
  • Humans
  • Ivermectin (administration & dosage, therapeutic use)
  • Loiasis (drug therapy, parasitology)
  • Microfilariae (isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: